Patents Examined by Kaijiang Zhang
  • Patent number: 11466321
    Abstract: An example of an array includes a support including a plurality of discrete wells, a gel material positioned in each of the discrete wells, a sequencing primer grafted to the gel material, and a non-sequencing entity grafted to the gel material. Each of the sequencing primer and the non-sequencing entity is in its as-grafted form.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: October 11, 2022
    Assignee: Illumina, Inc.
    Inventors: James Tsay, Yuxiang Huang
  • Patent number: 11466320
    Abstract: Branching phosphoramidite monomers and molecules having comb-like structures are disclosed and described. A branching phosphoramidite monomer having the structure is provided wherein R4 and R5 are independently —(O—CH2—CH2—)n where n is 1-5 or —O—(CH2—)n where n is 1-10, and R1, R2, and R3 are each one of dimethoxytrityl (DMT)—O—, levulinyl (Lev)—O—, and a phosphoramidite.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: October 11, 2022
    Assignee: University of Utah Research Foundation
    Inventors: John D. Phillips, Jennifer M. Heemstra
  • Patent number: 11467153
    Abstract: The present disclosure provides methods, systems, and kits for processing nucleic acid molecules. A method may comprise providing a template nucleic acid fragment (e.g., within a cell, cell bead, or cell nucleus) within a partition (e.g., a droplet or well) and subjecting the template nucleic acid fragment to one or more processes including a barcoding process and a single primer extension or amplification process. The processed template nucleic acid fragment may then be recovered from the partition and subjected to further amplification to provide material for subsequent sequencing analysis. The methods provided herein may permit simultaneous processing and analysis of both DNA and RNA molecules originating from the same cell, cell bead, or cell nucleus.
    Type: Grant
    Filed: August 3, 2021
    Date of Patent: October 11, 2022
    Assignee: 10X GENOMICS, INC.
    Inventors: Zahra Kamila Belhocine, Jason Bell, Jerald Sapida, Katrina Sullivan-Bibee
  • Patent number: 11459610
    Abstract: The present invention is concerned with compositions and methods for improving the rate of correct sample identification in indexed nucleic acid library preparations for multiplex next generation sequencing by exonuclease treatment and optionally blocking the 3? ends of pooled indexed polynucleotides from multiple samples prior to amplification and sequencing.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: October 4, 2022
    Assignee: ILLUMINA CAMBRIDGE LIMITED
    Inventors: Michael Chesney, Vincent Peter Smith, Claire Bevis-Mott, Jonathan Mark Boutell, Angela Kalbande
  • Patent number: 11441180
    Abstract: The present disclosure provides compositions and methods for accurately detecting mutations by uniquely tagging double stranded nucleic acid molecules with dual cyphers such that sequence data obtained from a sense strand can be linked to sequence data obtained from an anti-sense strand when sequenced, for example, by massively parallel sequencing methods.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: September 13, 2022
    Assignee: Fred Hutchinson Cancer Center
    Inventor: Jason H. Bielas
  • Patent number: 11434483
    Abstract: Provided in the present invention is a method for constructing single cell sequencing libraries, comprising the following steps: a) lysing a single cell to obtain a single cell lysate; b) separating the nucleus and the cytoplasm in the single cell lysate obtained in step a) to obtain a nuclear solution and a total RNA solution; and c) constructing a chromatin DNA library with the nuclear solution obtained in step b) to obtain a chromatin-accessibility sequencing library of the single cell; and constructing a transcriptome library with the total RNA solution obtained in step b) to obtain a transcriptome sequencing library of the single cell.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: September 6, 2022
    Assignee: MGI TECH CO., LTD.
    Inventors: Longqi Liu, Chuanyu Liu, Liang Wu, Zhouchun Shang, Mengnan Cheng, Yue Yuan, Liqin Xu, Xin Liu, Xun Xu
  • Patent number: 11427846
    Abstract: The disclosure provides a composition comprising a double-stranded deoxyribonucleic acid (dsDNA) sequence comprising from 5? to 3?, a sequence comprising a first adaptor sequence, a template sequence, and a second adaptor sequence, wherein the second adaptor sequence comprises a hybridization site for a template switching oligonucleotide (TSO). The disclosure provides methods for making the compositions of the disclosure using a template switching mechanism to add non-templated basepairs to the ends of a DNA molecule, hybridize a TSO to the non-templated basepairs, and then extend the sequence complementary to the TSO to add an adaptor.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: August 30, 2022
    Assignee: Kapa Biosystems, Inc.
    Inventors: Jennifer Hsieh, Paul McEwan, Martin Ranik, Marliz Strydom, Eric van der Walt, Ross Wadsworth
  • Patent number: 11415578
    Abstract: The bio sensor platform is a rapid point-of-care (POC) device wherein detection of a target analyte from a liquid or solid substrate is performed in a single step using a fully integrated disposable test system that includes a test strip immunoassay. In operation, a user initiates the test by rupturing the bottom of a liquid-filled analyte capsule seated in a capsule sleeve. A small volume of liquid flows by capillary action from the capsule sleeve and through a restrictor port to a test strip chamber where contact with the absorptive sample pad of the test strip (among other things) moves liquid by capillary action upwardly through the test strip. The detection of the target analyte is resolved by the test strip reagents and the test results are obtained at a test result window where a portion of the test strip is exposed to the user.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: August 16, 2022
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Robert M. Hnasko, Eric S. Jackson, Ronald P. Haff, Susan Uramoto
  • Patent number: 11414656
    Abstract: Methods for preparing sequencing libraries from a DNA-containing test sample, as well as methods for correcting sequencing-derived errors, are provided.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: August 16, 2022
    Assignee: GRAIL, Inc.
    Inventors: Lijuan Ji, Nathan Hunkapiller, Suchitra Ramani
  • Patent number: 11408033
    Abstract: This disclosure provides systems and methods for sample processing and data analysis. Sample processing may include nucleic acid sample processing and subsequent sequencing. Some or all of a nucleic acid sample may be sequenced to provide sequence information, which may be stored or otherwise maintained in an electronic storage location. The sequence information may be analyzed with the aid of a computer processor, and the analyzed sequence information may be stored in an electronic storage location that may include a pool or collection of sequence information and analyzed sequence information generated from the nucleic acid sample. Methods and systems of the present disclosure can be used, for example, for the analysis of a nucleic acid sample, for producing one or more libraries, and for producing biomedical reports. Methods and systems of the disclosure can aid in the diagnosis, monitoring, treatment, and prevention of one or more diseases and conditions.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: August 9, 2022
    Assignee: Personalis, Inc.
    Inventors: Gabor T. Bartha, Gemma Chandratillake, Richard Chen, Sarah Garcia, Hugo Yu Kor Lam, Shujun Luo, Mark R. Pratt, John West
  • Patent number: 11408029
    Abstract: Provided herein are methods of identifying a methylation status of an analyte in a biological sample. Also provided herein are methods that combine identifying the methylation status with spatial technology to identify the location of a methylation status in a biological sample.
    Type: Grant
    Filed: January 11, 2022
    Date of Patent: August 9, 2022
    Assignee: 10x Genomics, Inc.
    Inventors: Layla Katiraee, Michael Schnall-Levin, Christina Galonska, Marlon Stoeckius
  • Patent number: 11396677
    Abstract: This disclosure provides systems and methods for attaching nanopore-detectable tags to nucleotides. The disclosure also provides methods for sequencing nucleic acids using the disclosed tagged nucleotides.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: July 26, 2022
    Assignees: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, ROCHE SEQUENCING SOLUTIONS, INC.
    Inventors: Carl W. Fuller, Shiv Kumar, Jingyue Ju, Randall Davis, Roger Chen
  • Patent number: 11384394
    Abstract: This disclosure provides systems and methods for sample processing and data analysis. Sample processing may include nucleic acid sample processing and subsequent sequencing. Some or all of a nucleic acid sample may be sequenced to provide sequence information, which may be stored or otherwise maintained in an electronic storage location. The sequence information may be analyzed with the aid of a computer processor, and the analyzed sequence information may be stored in an electronic storage location that may include a pool or collection of sequence information and analyzed sequence information generated from the nucleic acid sample. Methods and systems of the present disclosure can be used, for example, for the analysis of a nucleic acid sample, for producing one or more libraries, and for producing biomedical reports. Methods and systems of the disclosure can aid in the diagnosis, monitoring, treatment, and prevention of one or more diseases and conditions.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: July 12, 2022
    Assignee: Personalis, Inc.
    Inventors: Gabor T. Bartha, Gemma Chandratillake, Richard Chen, Sarah Garcia, Hugo Yu Kor Lam, Shujun Luo, Mark R. Pratt, John West
  • Patent number: 11377695
    Abstract: The invention provides methods and reagents for diagnosing breast cancer that are based on the detection of biomarkers in the circulating nucleic acids from a patient to be evaluated.
    Type: Grant
    Filed: August 13, 2018
    Date of Patent: July 5, 2022
    Assignee: Chronix Biomedical
    Inventors: Ekkehard Schuetz, Julia Beck, Howard Urnovitz
  • Patent number: 11377676
    Abstract: Provided herein are methods, systems, and compositions for seamless nucleic acid assembly. Such methods, systems, and compositions for seamless nucleic acid assembly include those for in vitro recombination cloning, single-stranded hierarchal DNA assembly, or overlap extension PCR without primer removal.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: July 5, 2022
    Assignee: Twist Bioscience Corporation
    Inventors: Cheng-Hsien Wu, Sebastian Treusch
  • Patent number: 11371095
    Abstract: The invention relates to a high-throughput method for characterizing the genome-wide activity of editing nucleases in vitro.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: June 28, 2022
    Assignee: St. Jude Children's Research Hospital, Inc.
    Inventors: Shengdar Q. Tsai, Cicera R. Lazzarotto
  • Patent number: 11371088
    Abstract: Provided herein, among other things, are various in vitro methods that involve cleaving dsDNA molecules that comprise a mismatched nucleotide using EndoMS. In some embodiments, the method may comprise ligating a T-tailed double-stranded adapter to A-tailed double-stranded fragments of nucleic acid to produce ligation products that comprise adapter-ligated fragments and double-stranded adapter dimers that comprise a T:T mismatch at the ligation junction and cleaving both strands of the adapter dimers using EndoMS.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: June 28, 2022
    Assignee: New England Biolabs, Inc.
    Inventor: Andrew F. Gardner
  • Patent number: 11365411
    Abstract: This disclosure provides techniques and systems for efficient random access to digital data encoded in oligonucleotides (e.g., DNA). Random access to DNA-encoded data is provided by amplification using polymerase chain reaction (PCR) and primer pairs that selectively amplify only the oligonucleotides encoding a desired set of digital data. Multiple separate random-access requests are prepared for multiplex DNA sequencing by generating copy-normalized amplification products. Copy-normalized amplification products are efficiently created by performing multiple singleplex PCR reactions in parallel and measuring the quantity of oligonucleotides in each reaction. The PCR reactions are performed in parallel through the use of multiple isolated reaction volumes such as water-in-oil microdroplets or individual wells on a plate.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: June 21, 2022
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Yuan-Jyue Chen, Bichlien Nguyen, Karin Strauss
  • Patent number: 11365446
    Abstract: This disclosure provides systems and methods for sample processing and data analysis. Sample processing may include nucleic acid sample processing and subsequent sequencing. Some or all of a nucleic acid sample may be sequenced to provide sequence information, which may be stored or otherwise maintained in an electronic storage location. The sequence information may be analyzed with the aid of a computer processor, and the analyzed sequence information may be stored in an electronic storage location that may include a pool or collection of sequence information and analyzed sequence information generated from the nucleic acid sample. Methods and systems of the present disclosure can be used, for example, for the analysis of a nucleic acid sample, for producing one or more libraries, and for producing biomedical reports. Methods and systems of the disclosure can aid in the diagnosis, monitoring, treatment, and prevention of one or more diseases and conditions.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: June 21, 2022
    Assignee: Personalis, Inc.
    Inventors: Gabor T. Bartha, Gemma Chandratillake, Richard Chen, Sarah Garcia, Hugo Yu Kor Lam, Shujun Luo, Mark R. Pratt, John West
  • Patent number: 11352662
    Abstract: Technology provided herein relates in part to methods, processes, machines and apparatuses for determining sequences of nucleotides for nucleic acid templates in a nucleic acid sample. The technology provide herein also relates in part to methods, processes, machines and apparatuses for counting nucleic acid templates. Nucleic acid templates of a sample are tagged with nonrandom oligonucleotide adapters that include predetermined non-randomly generated sequences. The use of these nonrandom oligonucleotide adapters provides an efficient method to reduce sequencing errors, and increase the sensitivity of detection of low-frequency single nucleotide alterations.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: June 7, 2022
    Inventors: Taylor Jensen, Christopher Ellison